Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine H Smith

Showing results (81-90 of 169) with videos related to

Pageof 17
Sort By:
The Journal of Investigative Dermatology|April 9, 2013
The IL23R A/Gln381 allele promotes IL-23 unresponsiveness in human memory T-helper 17 cells and impairs Th17 responses in psoriasis patientsPaola Di Meglio, Federica Villanova, Luca Napolitano, et al.
Dermatology and Therapy|December 13, 2021
Continued Treatment with Dupilumab is Associated with Improved Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Not Achieving Optimal Responses with Short-Term TreatmentApril Armstrong, Andrew Blauvelt, Eric L Simpson, et al.
JAMA Dermatology|March 29, 2018
Comparison of Drug Discontinuation, Effectiveness, and Safety Between Clinical Trial Eligible and Ineligible Patients in BADBIRKayleigh J Mason, Jonathan N W N Barker, Catherine H Smith, et al.
The Journal of Investigative Dermatology|August 20, 2013
Generalized pustular eruptions: time to adapt the disease taxonomy to the genetic architecture?Alexander A Navarini, Laurence Valeyrie-Allanore, Niovi Setta-Kaffetzi, et al.
The Journal of Investigative Dermatology|January 30, 2013
Rare variations in IL36RN in severe adverse drug reactions manifesting as acute generalized exanthematous pustulosisAlexander A Navarini, Laurence Valeyrie-Allanore, Niovi Setta-Kaffetzi, et al.
JAMA Cardiology|September 18, 2024
Exploring the Link Between Genetic Predictors of Cardiovascular Disease and PsoriasisRavi Ramessur, Jake Saklatvala, Ashley Budu-Aggrey, et al.
Science Translational Medicine|October 13, 2017
An analysis of IL-36 signature genes and individuals with <i>IL1RL2</i> knockout mutations validates IL-36 as a psoriasis therapeutic targetSatveer K Mahil, Marika Catapano, Paola Di Meglio, et al.
The Journal of Investigative Dermatology|January 1, 2021
CYP1A1 Enzymatic Activity Influences Skin Inflammation Via Regulation of the AHR PathwayMariela Kyoreva, Ying Li, Mariyah Hoosenally, et al.
The Journal of Investigative Dermatology|November 17, 2015
Establishing an Academic-Industrial Stratified Medicine Consortium: Psoriasis Stratification to Optimize Relevant TherapyChristopher E M Griffiths, Michael R Barnes, A David Burden, et al.
JAMA Dermatology|June 6, 2019
Prevalence of Advanced Liver Fibrosis in Patients With Severe PsoriasisCatriona M Maybury, Heather F Porter, Ewa Kloczko, et al.
Pageof 17

Showing results (81-90 of 169) with videos related to

Sort By:
Pageof 17
The Journal of Investigative Dermatology|April 9, 2013
The IL23R A/Gln381 allele promotes IL-23 unresponsiveness in human memory T-helper 17 cells and impairs Th17 responses in psoriasis patientsPaola Di Meglio, Federica Villanova, Luca Napolitano, et al.
Dermatology and Therapy|December 13, 2021
Continued Treatment with Dupilumab is Associated with Improved Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Not Achieving Optimal Responses with Short-Term TreatmentApril Armstrong, Andrew Blauvelt, Eric L Simpson, et al.
JAMA Dermatology|March 29, 2018
Comparison of Drug Discontinuation, Effectiveness, and Safety Between Clinical Trial Eligible and Ineligible Patients in BADBIRKayleigh J Mason, Jonathan N W N Barker, Catherine H Smith, et al.
The Journal of Investigative Dermatology|August 20, 2013
Generalized pustular eruptions: time to adapt the disease taxonomy to the genetic architecture?Alexander A Navarini, Laurence Valeyrie-Allanore, Niovi Setta-Kaffetzi, et al.
The Journal of Investigative Dermatology|January 30, 2013
Rare variations in IL36RN in severe adverse drug reactions manifesting as acute generalized exanthematous pustulosisAlexander A Navarini, Laurence Valeyrie-Allanore, Niovi Setta-Kaffetzi, et al.
JAMA Cardiology|September 18, 2024
Exploring the Link Between Genetic Predictors of Cardiovascular Disease and PsoriasisRavi Ramessur, Jake Saklatvala, Ashley Budu-Aggrey, et al.
Science Translational Medicine|October 13, 2017
An analysis of IL-36 signature genes and individuals with <i>IL1RL2</i> knockout mutations validates IL-36 as a psoriasis therapeutic targetSatveer K Mahil, Marika Catapano, Paola Di Meglio, et al.
The Journal of Investigative Dermatology|January 1, 2021
CYP1A1 Enzymatic Activity Influences Skin Inflammation Via Regulation of the AHR PathwayMariela Kyoreva, Ying Li, Mariyah Hoosenally, et al.
The Journal of Investigative Dermatology|November 17, 2015
Establishing an Academic-Industrial Stratified Medicine Consortium: Psoriasis Stratification to Optimize Relevant TherapyChristopher E M Griffiths, Michael R Barnes, A David Burden, et al.
JAMA Dermatology|June 6, 2019
Prevalence of Advanced Liver Fibrosis in Patients With Severe PsoriasisCatriona M Maybury, Heather F Porter, Ewa Kloczko, et al.
Pageof 17